FDA Adverse Event Injury Summary report: N

TAXUS¿ ELEMENT¿ LONG

MDR report key: 2961964 · Received February 14, 2013

Report

Report Number
2134265-2013-00639
Event Type
Injury
Date Received
February 14, 2013
Date of Event
November 27, 2012
Report Date
January 18, 2013
Manufacturer
BOSTON SCIENTIFIC - GALWAY
Product Code
NIQ
PMA / PMN Number
P100023
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
SP
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

PATIENT IDENTIFIER: (B)(6). DEVICE IS A COMBINATION PRODUCT. DEVICE EVALUATED BY MFR: IT IS INDICATED THAT THE DEVICE WILL NOT BE RETURNED FOR EVALUATION; THEREFORE A FAILURE ANALYSIS OF THE COMPLAINT DEVICE COULD NOT BE COMPLETED. THE MANUFACTURING BATCH RECORD REVIEW CONFORMED THAT THE DEVICE MET ALL MATERIAL, ASSEMBLY AND PERFORMANCE SPECIFICATIONS. THE MOST PROBABLE ROOT CAUSE IS ANTICIPATED PROCEDURAL COMPLICATION AS THE REPORTED EVENT IS DUE TO A KNOWN PHYSIOLOGICAL EFFECT OF THE PROCEDURE NOTED WITHIN THE PRODUCT DIRECTIONS FOR USE (DFU) AND/OR DEVICE LABELING. (B)(4).

Description of Event or Problem · 1

(B)(4) STUDY. SAME CASE AS MDR ID#: 2134265-2013-00638. IT WAS REPORTED THAT FOLLOWING A CORONARY ARTERY STENTING TREATMENT PROCEDURE, THE PATIENT IN-STENT RESTENOSIS AND REQUIRED A TARGET VESSEL REVASCULARIZATION (TVR). IN (B)(6) 2011, THE PATIENT PRESENTED DUE TO UNSTABLE ANGINA (BRAUNWALD CLASSIFICATION IIIB) AND WAS REFERRED FOR CARDIAC CATHETERIZATION. THE 1ST DE NOVO TARGET LESION WAS A LONG LESION LOCATED IN THE MID RIGHT CORONARY ARTERY (MID RCA) WITH 70% STENOSIS AND WAS 20MM LONG WITH A REFERENCE VESSEL DIAMETER OF 2.80MM. THE PHYSICIAN TREATED THE LESION WITH PRE-DILATION AND PLACEMENT OF A 3.00X38MM TAXUS ELEMENT STENT, WITH 0% RESIDUAL STENOSIS FOLLOWING POST-DILATION. THE 2ND DE NOVO TARGET LESION WAS A LONG LESION LOCATED IN THE MID RIGHT CORONARY ARTERY (MID RCA) WITH 70% STENOSIS AND WAS 23MM LONG WITH A REFERENCE VESSEL DIAMETER OF 3.4MM. THE PHYSICIAN TREATED THE LESION WITH PRE-DILATION AND PLACEMENT OF A 3.50X38MM TAXUS ELEMENT STENT, WITH 0% RESIDUAL STENOSIS FOLLOWING POST-DILATION. THE PATIENT WAS DISCHARGED ON ASPIRIN AND CLOPIDOGREL. IN (B)(6) 2012, THE PATIENT WAS HOSPITALIZED AND REFERRED FOR CARDIAC CATHETERIZATION. CORONARY ANGIOGRAPHY REVEALED 70% FOCAL RESTENOSIS OF THE PREVIOUSLY PLACED STUDY STENT IN THE MID RCA, WHICH WAS TREATED WITH BALLOON ANGIOPLASTY, WITH 0% RESIDUAL STENOSIS. THE EVENT WAS CONSIDERED AS RESOLVED WITHOUT RESIDUAL EFFECTS AND THE PATIENT WAS DISCHARGED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
65253 TAXUS¿ ELEMENT¿ LONG CORONARY DRUG-ELUTING STENT NIQ BOSTON SCIENTIFIC - GALWAY H7493902538350 13379949

Patients

Seq Age Sex Outcome Treatment
1 61 YR Hospitalization| R